- Protocol Short Name and Number: Follicular Lymphoma, 0202
- Protocol Long Name: Autologous vs. Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Patients with Chemosensitive Follicular Non-Hodgkin’s Lymphoma Beyond First Complete Response or First Partial Response
- Protocol (PDF)
- Informed Consents
- Frequently Asked Questions
- Key Personnel
- BMT CTN # 0202 Protocol Co-Chair: Ginna Laport, MD
- BMT CTN # 0202 Protocol Co-Chair: Robert Negrin, MD
- BMT CTN # 0202 Protocol Officer: Marcie Tomblyn, MD
- BMT CTN # 0202 Protocol Medical Monitor: Mary Eapen, MD
- BMT CTN # 0202 Protocol Coordinator: bmtctn@emmes.com
- Keywords: Lymphoma, Follicular, Non-Hodgkin’s Lymphoma, NHL, Autologous Transplant, Auto Transplant, Auto, Allo Transplant, Allogeneic Transplant, Allo, Pediatric, Quality of Life, QOL, Non-myeloablative, Child, Children, Teen, Adolescent
This protocol closed to patient accrual on March 2, 2006.